ESR1 and breast carcinoma: The main molecular biomarkers currently used in the diagnosis and treatment of breast cancer include estrogen receptor (ER), progesterone receptor (PR), cell proliferation antigen Ki67, and human epidermal growth factor receptor 2 (HER-2).